Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Phoenix Biotechnology
AddedFeb 15, 2024
UpdatedJun 18, 2026
Phoenix Biotechnology

Phoenix Biotechnology

Series A

Phoenix Biotechnology: Pioneering cancer treatment research and therapeutic agent development.

HQ
San Antonio, TX, US
Founded
2003
Overview
Compare
Fundraising
Employees
Website

Phoenix Biotechnology, founded in Texas, is dedicated to the research and development of therapeutic agents and treatment regimens for cancer, antiviral, and neuro-degenerative diseases. The company specializes in creating safe and effective natural products, particularly focusing on the therapeutic potential of Nerium oleander. Their core mission is to address diseases with unmet medical needs and significant economic impacts on livestock health, aiming to make their treatments widely accessible at low costs.

Notable figures associated with Phoenix Biotechnology include leading researchers and scientists in the field of oncology and virology. The company has garnered attention from key investors interested in innovative cancer treatments. Among its achievements, Phoenix Biotechnology has developed promising data that support the efficacy and safety of their natural products, positioning them as a significant player in the biotech industry. Their impact is marked by a commitment to advancing medical science and improving patient outcomes through natural therapeutic solutions.

Phoenix Biotechnology - Similar Companies

Nerium Biotechnology logo

Nerium Biotechnology

nbiresearch.com

Phoenix Life Sciences International logo

Phoenix Life Sciences International

phoenixlife.co

Nerx Biosciences logo

Nerx Biosciences

BioNumerik Pharmaceuticals logo

BioNumerik Pharmaceuticals

Puma Biotechnology logo

Puma Biotechnology

Phoenix PharmaLabs logo

Phoenix PharmaLabs

PNP Therapeutics logo

PNP Therapeutics

Phigenix logo

Phigenix

phigenix.com

Tigris Pharmaceuticals logo

Tigris Pharmaceuticals

tigrispharma.com

Oncolix logo

Oncolix

NanoPharmaceuticals logo

NanoPharmaceuticals

Biotheryx logo

Biotheryx

biotheryx.com

PDX Pharmaceuticals logo

PDX Pharmaceuticals

pdxpharm.com

NantBio logo

NantBio

Phoenix S&T logo

Phoenix S&T

phoenix-st.com

Phoenix Biotechnology - Quick Facts

Who are Phoenix Biotechnology's competitors?

Companies similar to Phoenix Biotechnology include Nerium Biotechnology, Phoenix Life Sciences International, Nerx Biosciences and BioNumerik Pharmaceuticals.

When was Phoenix Biotechnology founded?

Phoenix Biotechnology was founded in 2003.

Where is Phoenix Biotechnology's headquarters located?

Phoenix Biotechnology's headquarters is located in San Antonio, TX, US.

When was Phoenix Biotechnology's last funding round?

Phoenix Biotechnology's most recent funding round was for $5M (USD) in August 2020.

How much has Phoenix Biotechnology raised to-date?

As of Aug 12, 2020, Phoenix Biotechnology has raised a total of $10.9M (USD).

How many employees does Phoenix Biotechnology have?

Phoenix Biotechnology has 6 employees as of Feb 5, 2024.

Phoenix Biotechnology - Classification

Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Cancer Treatment
Tags
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 610Extraction of crude petroleum
Show 20 more industry codes
NAICS
  • 210000Mining, Quarrying, and Oil and Gas Extraction
  • 211000Oil and Gas Extraction
  • 211100Oil and Gas Extraction
  • 211120Crude Petroleum Extraction
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 1300Oil And Gas Extraction
  • 1310Crude Petroleum And Natural Gas
  • 1311Crude Petroleum And Natural Gas
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified